News

Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck.
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...
One estimate of the profit hit from Trump's executive order on drug pricing
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
Merck’s New Keytruda Shot Is a Rare Real-Time ‘Product Hop’ (1)
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
Pharma stocks recover from initial shock of Trump's drug pricing order
Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...
Benzinga.com3d
Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket
Why It Matters: This move is expected to have the biggest impact on Medicare Part B drugs, which mainly constitute outpatient prescriptions and biologicals, the prices for which are directly ...
Gulf News2d
Trump to cut drug prices: Will US drug savings drive up costs worldwide?
In Japan, the pharma index posted its biggest daily drop in months, and US giants such as Pfizer, Merck ... renewed push to lower drug prices may have an enormous impact on the sector’s ...
WZZM3d
Trump signs executive order setting 30-day deadline for drugmakers to lower prescription drug costs
Drugmakers have long argued that any threats to their profits could impact the research they do to develop new drugs. “Importing foreign prices from ... Monday morning. Merck, a company that ...
FACT FOCUS: Trump Blames Other Countries for High US Drug Prices. Experts Say It's Not Their Fault
President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower ...